CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 510295-510378 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"The increase of serum IL-10 after IAPP was suppressed with combined IVMP treatment.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T36726","span":{"begin":0,"end":83},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T36726","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T99","span":{"begin":0,"end":83},"obj":"Sentence"}],"attributes":[{"subj":"T99","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2196","span":{"begin":16,"end":21},"obj":"Body_part"}],"attributes":[{"id":"A2196","pred":"uberon_id","subj":"T2196","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"subj":"T2196","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ece893","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ce93ec"},{"id":"CORD-19-PD-UBERON","color":"#93ecb4"}]}]}}